2. 筋萎縮性側索硬化症 Amyotrophic lateral sclerosis Clinical trials / Disease details

臨床試験数 : 624 / 薬物数 : 611 - (DrugBank : 160) / 標的遺伝子数 : 172 - 標的パスウェイ数 : 225

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2015-001431-20-NL (EUCTR)	17/08/2015	21/04/2015	Trial to look at the nerve conductance in patients with ALS, with and without Riluzole or Retigabine ...	A randomized, double blind, double-dummy placebo controlled, 3-way cross-over study to determine the ...	Amytrophic Lateral Sclerosis MedDRA version: 18.1;Level: PT;Classification code 10002026;Term: Amyot ...	Trade Name: Rilutek 50 mg film-coated tablets Product Name: Rilutek INN or Proposed INN: RILUZOLE Trade ...	Centre for Human Drug Research	NULL	Not Recruiting			Female: yes Male: yes		Phase 2	Netherlands
2	NCT02450552 (ClinicalTrials.gov)	June 2015	19/5/2015	Clinical Trial of Ezogabine (Retigabine) in ALS Subjects	A Phase 2 Pharmacodynamic Trial of Ezogabine(Retigabine) on Neuronal Excitability in Amyotrophic Lat ...	Amyotrophic Lateral Sclerosis	Drug: Ezogabine;Drug: Placebo	Brian Wainger	ALS Association;GlaxoSmithKline;Harvard University;Massachusetts General Hospital	Completed	18 Years	80 Years	All	65	Phase 2	United States

First Previous1Next Last